低分子量肝素作为桥梁抗凝剂在机械心脏门更换后的早期
Philippe Meurin1, Jean Yves Tabet, Hélène Weber
1Les Grands Prés, Villeneuve Saint Denis, France. philippemeurin@hotmail.com
Circulation
|February 2, 2006
概括
低分子量氨酸,特别是埃诺沙巴林,在维生素K对抗剂尚未有效时,对于机械心脏置换后的患者来说,是一种可行的桥梁抗凝药选择. 这种方法可以在高风险的术后期降低血栓栓塞的风险.
科学领域:
- 心脏病学 心脏病学
- 血管外科 血管外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 机械心脏门置换 (MHVR) 通常需要抗凝药.
- 维生素K对抗剂 (VKA) 可能是禁忌的,或者在MHVR后达到治疗水平的速度很慢.
- 有时使用未分离的氨酸,但正在探索低分子量氨酸 (LMWH) 的可行性.
研究的目的:
- 调查使用埃诺沙巴林 (LMWH) 作为MHVR后患者的桥梁抗凝药的可行性.
- 评估尚未接受有效VKA治疗的患者的安全性和疗效.
主要方法:
- 对695名转移到心脏康复中心的MHVR患者进行前性研究.
- 招募了250名患者,在VKA有效之前,他们接受素而不是未分离的肝素,直到VKA有效.
- 患者进行了90天的随访,监测出血,血栓栓塞和膜血栓.
主要成果:
- 埃诺沙巴林治疗的平均时间为8.3天.
- 发生了两次主要和三次轻微出血.
- 据报道,有一次过渡性缺血性发作.
- 没有观察到膜血栓塞或死亡.
结论:
- 对于MHVR后的患者来说,以诺沙林桥梁抗凝药是可行的.
- 在VKA治疗完全治疗之前,这种策略在高风险时期是有效的.
- 在特定的MHVR患者中,LMWH可能会缩短住院时间.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...


